| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2006 | US7022688 Use of 17β-dihydroequilenin as an antioxidant |
| 04/04/2006 | US7022687 for treatment of allergies and airway disorders such as allergic rhinitis |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022685 Compound for use in the treatment and prevention of infections in animals and humans |
| 04/04/2006 | US7022684 Treatment of rumen acidosis with α-amylase inhibitors |
| 04/04/2006 | US7022683 Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
| 04/04/2006 | US7022682 the co-administration of L-Arginine and Rhamnan Sulfate in a food or beverage for preventing and/or treating, type II diabetes mellitus, and its complications, without increasing the patient's risk of hemorrhaging |
| 04/04/2006 | US7022681 Cardiovascular disorders; antiemetic agents; antiischemic agents; central nervous system disorders; dietetics |
| 04/04/2006 | US7022680 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases |
| 04/04/2006 | US7022678 Pregabalin lactose conjugates |
| 04/04/2006 | US7022671 Surfactant protein C esters |
| 04/04/2006 | US7022667 Mycobacterium; grampositive bacteria bactericides, antibiotics |
| 04/04/2006 | US7022663 Comprising as active ingredient a therapeutically effective amount of Copolymer 1 (glatiramer acetate), and microcrystalline cellulose; treatment of autoimmune diseases |
| 04/04/2006 | US7022521 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 04/04/2006 | US7022512 Isolated biomass containing microorganisms which produce omega-3-highly unsaturated fatty acids( containing 4 or more double bonds) suitable for human and animal consumption as food additives or for use in pharmaceutical and industrial products |
| 04/04/2006 | US7022484 Methods for treating neuropathological states and neurogenic inflammatory states and methods for identifying compounds useful therein |
| 04/04/2006 | US7022350 Dietary supplement |
| 04/04/2006 | US7022349 Antihistamine composition |
| 04/04/2006 | US7022345 Oral solid pharmaceutical formulations with pH-dependent multiphasic release |
| 04/04/2006 | US7022343 In situ polymerization on heart; biodegradation |
| 04/04/2006 | US7022342 Controlled release oral dosage form of beta-adrenergic blocking agents |
| 04/04/2006 | US7022341 Mixture of antihistamine and decongestant; antiallergens; multilayer tablet |
| 04/04/2006 | US7022339 Antidiabetic preparation for oral administration |
| 04/04/2006 | US7022337 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
| 04/04/2006 | US7022336 Methods for attaching proteins to lipidic microparticles with high efficiency |
| 04/04/2006 | US7022335 Suppository of retaining in lower region of rectum |
| 04/04/2006 | US7022332 Sulfacetamide formulations for treatment of rosacea |
| 04/04/2006 | US7022330 Dissolving epothilone analog such as ixabepilone in a mixture of tertiary-butanol in water to form a solution; drying solution; lyophilizing; drying in vacuum; packaging lyophilized product in a first vial and packaging second vial with nonionic surfactant |
| 04/04/2006 | US7022328 Therapeutic and diagnostic compositions |
| 04/04/2006 | US7022318 Kit of parts for treating urinary incontinence in mammals |
| 04/04/2006 | US7022317 Heterocyclic derivatives of 2-oxothiazolidine-4-carboxylic acid, and use as active photoprotective agents |
| 04/04/2006 | US7022315 Administering a thiol-based chemoprotectant agent intra-arterially for therapy and prophylaxis of side effects of cytotoxic cancer therapy for tumors located in the brain, head or neck |
| 04/04/2006 | US7022314 Anti-plaque emulsions and products containing same |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | CA2356544C Pyridotriazines and pyridopyridazines |
| 04/04/2006 | CA2354123C New benzothiadiazine derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/04/2006 | CA2341031C Novel salt form of pantoprazole |
| 04/04/2006 | CA2327393C Solution for the preparation of a pharmaceutical substance for diagnosing and/or treating tissue pathologies |
| 04/04/2006 | CA2291075C Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions |
| 04/04/2006 | CA2262745C Highly lipophilic camptothecin derivatives |
| 04/04/2006 | CA2259407C Drug delivery devices and process of manufacture |
| 04/04/2006 | CA2258764C Inhibitors of oleamide hydrolase |
| 04/04/2006 | CA2257303C Biconvex rapidly disintegrating dosage forms |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 04/04/2006 | CA2235765C Azulenyl nitrone spin trapping agents, methods of making and using same |
| 04/04/2006 | CA2235133C Esters of 3-hydroxy-piperidinemethanol derivatives |
| 04/04/2006 | CA2222785C Vitamin d analogues |
| 04/04/2006 | CA2198266C Novel benzimidazole derivatives |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 04/04/2006 | CA2188507C Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 04/04/2006 | CA2181072C Estradiol penetration enhancers |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 04/04/2006 | CA2103022C Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 04/04/2006 | CA2075278C Folded sheet means |
| 03/31/2006 | CA2580563A1 Benzofuran derivatives |
| 03/30/2006 | WO2006034512A2 Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes |
| 03/30/2006 | WO2006034511A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 03/30/2006 | WO2006034510A2 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
| 03/30/2006 | WO2006034507A2 Methods of diagnosing and treating complications of pregnancy |
| 03/30/2006 | WO2006034495A2 Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects |
| 03/30/2006 | WO2006034491A2 Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes |
| 03/30/2006 | WO2006034480A2 Sulfonamide bicyclic compounds |
| 03/30/2006 | WO2006034474A2 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034473A2 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034468A2 Methods and compositions for treating hyperglycemic, hyperlipidemic, or hyperinsulinemic disorders |
| 03/30/2006 | WO2006034463A2 Herbal supplement to support weight loss |
| 03/30/2006 | WO2006034451A2 Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| 03/30/2006 | WO2006034441A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | WO2006034440A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | WO2006034435A2 Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions |
| 03/30/2006 | WO2006034418A2 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | WO2006034414A2 Loxapine analogs and methods of use thereof |
| 03/30/2006 | WO2006034402A2 Compounds for inflammation and immune-related uses |
| 03/30/2006 | WO2006034392A2 Therapeutic quinones |
| 03/30/2006 | WO2006034391A2 Indole inhibitors of 15-lipoxygenase |
| 03/30/2006 | WO2006034390A2 Inhibitors of 15-lipoxygenase |
| 03/30/2006 | WO2006034361A2 Dopaminergic mimetics |
| 03/30/2006 | WO2006034343A2 methods for regulating neurotransmitter systems by inducing counteradaptationS |
| 03/30/2006 | WO2006034338A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 03/30/2006 | WO2006034337A2 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
| 03/30/2006 | WO2006034333A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 03/30/2006 | WO2006034325A2 Method of treatment for or protection against lymphedema |
| 03/30/2006 | WO2006034317A2 Chemical compounds |
| 03/30/2006 | WO2006034312A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 03/30/2006 | WO2006034266A2 Sulfonyl hydrazines as hypoxia-selective antineoplastic agents |
| 03/30/2006 | WO2006034262A2 Method and composition for treating patients undergoing kidney dialysis |
| 03/30/2006 | WO2006034239A2 Antimicrobial mesoporous silica nanoparticles |
| 03/30/2006 | WO2006034235A2 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 03/30/2006 | WO2006034234A1 Crystalline form 3 of atrasentan hydrochloride |
| 03/30/2006 | WO2006034219A2 Inactivation of microorganisms with multidrug resistance inhibitors and phenothiaziniums |
| 03/30/2006 | WO2006034190A2 Purine derivatives and methods of use thereof |
| 03/30/2006 | WO2006034187A2 Use of memantine (namenda) to treat autism, compulsivity, and impulsivity |
| 03/30/2006 | WO2006034154A2 Salts of 5-azacytidine |
| 03/30/2006 | WO2006034116A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | WO2006034113A2 Quinolone analogs as cell proliferation inhibitors |
| 03/30/2006 | WO2006034111A1 (arylamidoaryl)squaramide compounds |
| 03/30/2006 | WO2006034110A1 (arylamidoaryl) cyanoguanidine compounds as inhibitors of c-kit proto-oncogene |
| 03/30/2006 | WO2006034094A1 Crystalline form 1 of atrasentan hxdrochloride |
| 03/30/2006 | WO2006034090A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |